The racing industry’s Racing Medication and Testing Consortium (RMTC) plans to reorganize its own Scientific Advisory Committee but does not plan to merge with the Association of Racing Commissioners International (RCI).

The RMTC’s executive committee met Dec. 17 to consider a recent letter from RCI inviting the RMTC to merge with RCI’s new Drug Testing Standards and Practices Committee.

Executive committee members reaffirmed an Oct. 13 board decision to conduct strategic planning on future research needs, and to reorganize the RMTC Scientific Advisory Committee and its processes to adapt and respond to new drugs, practices, and substances which threaten the integrity of racing, an RMTC release said.

Further, the executive committee affirmed the importance of maintaining an independent and apolitical RMTC for equine drug and therapeutic medication research, the release said, noting RMTC’s efforts have led to significant changes that have improved U.S. drug testing capabilities and medication regulation from its current independent position

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.